Fractyl Health
LEXINGTON, MA · Founded 2010 · CIK 0001572616 · Medtech · Public
Endoscopic metabolic surgery device that remodels the intestinal lining to treat obesity and type 2 diabetes
fractyl.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $274M
- 7 Form D · Jan 2022
- 56 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 17 granted · 23 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $14,347,541 | |
| Private capital raised | Form D · SEC | $19,764,908 | |
| Private capital raised | Form D · SEC | $37,168,830 | |
| Private capital raised | Form D · SEC | $38,376,508 | |
| Private capital raised | Form D · SEC | $44,750,503 | |
| Private capital raised | Form D · SEC | $99,999,949 | |
| Private capital raised | Form D · SEC | $20,075,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1296 | Vital Connect, Inc. | — | $83M |
| 1297 | TSRL, INC. | — | — |
| 1298 | Activated Research Company, LLC | — | — |
| 1299 | Fractyl Health | — | $274M |
| 1300 | CAMBIUM MEDICAL TECHNOLOGIES, LLC | — | — |
| 1301 | NAVINETICS NEUROMODULATION, INC. | — | — |
| 1302 | CENSYN INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- JOHN AMATRUDADirector
- KELLY BARNESDirector
- MARGARET BORYSExecutive Officer
- WILLIAM BRADLEYDirector
- Jay CaplanDirector · Executive Officer
- JAY CAPLANDirector · Executive Officer
- LISA DAVIDSONExecutive Officer
- Brian DoveyDirector
- BRIAN DOVEYDirector
- MARC ELIADirector
- Christopher GabrieliDirector
- CHRISTOPHER GABRIELIDirector
- MICHAEL HUANGDirector
- Stanley LapidusDirector
- STANLEY LAPIDUSDirector
- JUAN CARLOS LOPEZ-TALAVERAExecutive Officer
- Diane MarcouExecutive Officer
- CLIVE MEANWELLDirector
- Harith RajagopalanDirector · Executive Officer
- HARITH RAJAGOPALANDirector · Executive Officer
- Ajay RoyanDirector
- AJAY ROYANDirector
- AMY SCHULMANDirector
- Nimesh ShahDirector
- NIMESH SHAHDirector
- Hemant TanejaDirector
- Allan WillDirector
- ALLAN WILLDirector
Patents
- Tissue Treatment Devices, Systems, And Methodsgranted
- Gene Therapy Compositions, Methods, And Systems For Weight Loss And Maintenanceapplication
- Electrical Energy Ablation Systems, Devices And Methods For The Treatment Of Tissueapplication
- Tissue Treatment System With Fluid Delivery Consolegranted
- Intestinal Catheter Device And Systemapplication
- Injectate Delivery Devices, Systems And Methodsapplication
- Gene Therapies For Metabolic Disordersapplication
- Methods And Systems For Treating Diabetes And Related Diseases And Disordersapplication
- Automated Tissue Treatment Devices, Systems, And Methodsapplication
- Systems, Devices And Methods For Performing Medical Procedures In The Intestineapplication
- Electrical Energy Ablation Systems, Devices And Methods For The Treatment Of Tissuegranted
- Automated Tissue Treatment Devices, Systems, And Methodsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.